Literature DB >> 15296074

Beta-carotene is accumulated, metabolized, and possibly converted to retinol in human breast carcinoma cells (MCF-7).

Alexandre G Torres1, Radovan Borojevic, Nadia M F Trugo.   

Abstract

The aims of the present study were to investigate the uptake, accumulation, and metabolism of beta-carotene by the human breast carcinoma cell line MCF-7. Beta-carotene uptake was time- and dose-dependent, and independent of cell polarity. Beta-carotene accumulation in cells was linear as a function of its concentration in medium (1.3-4.1 micromol/L). It was accompanied by increasing amounts of retinol, which accumulated in cells following a sigmoid pattern, and by other four putative metabolites. Beta-apocarotenals, epoxides, endoperoxides, retinal, retinoic acid, and retinyl esters were not detected in cell extracts. Beta-carotene and its metabolites did not induce alterations in cell morphology or subcellular localization of epithelial mucins. Beta-carotene and retinol were released from cells that had previously accumulated beta-carotene, and were further incubated in beta-carotene- and retinol-free medium, but intracellular retinol content remained constant whereas beta-carotene decreased. In conclusion, beta-carotene added to culture medium in physiological concentrations (1-6 micromol/L) is taken up and metabolized in MCF-7 cells, and is possibly converted to retinol.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15296074     DOI: 10.1024/0300-9831.74.3.171

Source DB:  PubMed          Journal:  Int J Vitam Nutr Res        ISSN: 0300-9831            Impact factor:   1.784


  1 in total

1.  Longitudinal biological exposure to carotenoids is associated with breast cancer-free survival in the Women's Healthy Eating and Living Study.

Authors:  Cheryl L Rock; Loki Natarajan; Minya Pu; Cynthia A Thomson; Shirley W Flatt; Bette J Caan; Ellen B Gold; Wael K Al-Delaimy; Vicky A Newman; Richard A Hajek; Marcia L Stefanick; John P Pierce
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-03       Impact factor: 4.254

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.